
Biocon Biologics gets $90 mn contract from Malaysian government to supply human insulin
The Hindu
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices, and health clinics
More Related News

Arohan Financial Services plans to hit capital market during middle of 2026-27 with ₹1,500 crore IPO
Arohan Financial Services plans a ₹1,500 crore IPO in 2026-27 to strengthen its capital base and expand services.












